Translational Development Acquisition (TDACU) Total Liabilities (2023 - 2026)

Translational Development Acquisition has reported Total Liabilities for 4 years, with the latest figure at $6.9 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 8.46% year-over-year to $6.9 million; the trailing twelve-month figure through Mar 2026 stood at $6.9 million (up 8.46% YoY), and the FY2025 full-year result was $6.6 million, up 5.34% from the prior year.
• Total Liabilities for Q1 2026 stood at $6.9 million, up from $6.6 million in the prior quarter.
• The five-year high for Total Liabilities was $6.9 million in Q1 2026, with the low at $509343.0 in Q2 2024.
• Historically, Total Liabilities has averaged $4.5 million across 4 years, with a median of $6.3 million in 2025.
• The largest YoY upside for Total Liabilities was 1141.24% in 2025 against a maximum downside of 5.34% in 2025.
• Translational Development Acquisition's Total Liabilities stood at $509679.0 in 2023, then jumped by 1125.83% to $6.2 million in 2024, then rose by 5.34% to $6.6 million in 2025, then rose by 4.82% to $6.9 million in 2026.
• The last three Total Liabilities figures came in at $6.9 million (Q1 2026), $6.6 million (Q4 2025), and $6.5 million (Q3 2025), per Business Quant data.